Results 261 to 270 of about 441,361 (298)

Thymidine exerts anti-doxorubicin-induced cardiomyopathy effect through the regulation of the PPAR signaling pathways and ferroptosis pathways. [PDF]

Front Pharmacol
Li B, Wang Q, Zhou J, Li P, Sun C, Xia Q, Zhang Y.   +6 more
europepmc   +1 more source

Molecular genetics of arrhythmogenic right ventricular cardiomyopathy in South Africa

, 2011
Janine Blanckenberg
openalex   +1 more source

Russell’s viper venom induced reverse takotsubo cardiomyopathy

Rajeev Aravindakshan, A NATARAJAN, Aarsha Sadar   +2 more
openalex   +2 more sources

Re‐PERFUSE: Phase 1b study of AZD3427, a novel relaxin receptor agonist, on renal perfusion in HFrEF patients

ESC Heart Failure, EarlyView.
Abstract Aims Renal impairment frequently coexists with heart failure (HF) and is associated with increased risk of poor clinical outcomes. This highlights the urgent need for therapies targeting both cardiac and renal dysfunction. AZD3427, a long‐acting recombinant fusion protein and relaxin analogue that selectively activates the relaxin family ...
Marcin Ufnal, Macarena P. Quintana‐Hayashi, Kathleen Connolly, Daniel Pettersen, Zsolt Cselényi, Aurelija Jucaite, Magnus Schou, Andrea Varrone, Melanie Chan, Lars H. Lund   +9 more
wiley   +1 more source

Metabolic perturbations in cardiomyopathies: implications for early diagnosis and targeted interventions. [PDF]

Front Cardiovasc Med
Al-Shahrabi R, Al Mansoori G, Al-Saffar M, Akawi N.   +3 more
europepmc   +1 more source

Artificial Intelligence in Restrictive Cardiomyopathy: Current Diagnostic Applications and Future Directions

Rasi Mizori, Ali Hassan, Sukruth Pradeep Kundur, Ali Malik, Serdar Farhan, Sanjay Sivalokanathan   +5 more
openalex   +1 more source

A new staging system for hereditary transthyretin amyloidosis in the era of specific amyloidosis therapies

ESC Heart Failure, EarlyView.
The aim of our study was to develop a more accurate staging system for hereditary ATTR patients currently receiving specific treatment. A staging system was created using as criteria: GLS ≤ −11%, NT‐proBNP ≤ 2,000 ng/L, and eGFR ≤ 65 mL/min. We managed to accurately stratify patients into three disease stages, significantly different in terms of ...
Gabriela Neculae, Amira Zaroui, Robert Adam, Mounira Kharoubi, Benoit Funalot, Daniel Coriu, Ruxandra Jurcut, Thibaud Damy   +7 more
wiley   +1 more source

Multiparametric cardiac magnetic resonance evaluation of myocardial involvement in Duchenne muscular dystrophy: A case report. [PDF]

Radiol Case Rep
Takamure H, Oda S, Kidoh M, Ichiguchi Y, Nomura K, Hanatani S, Nakamura K, Tsujita K, Hirai T.   +8 more
europepmc   +1 more source

Percutaneous endocardial alginate–hydrogel injection in the treatment of heart failure: First‐in‐human study

ESC Heart Failure, EarlyView.
Using EndoWings™ and XDROP™, we developed a percutaneous minimally invasive technique for sequential circumferential alginate hydrogel injection into LV free mid‐wall. This human study assessed its safety/feasibility in HFrEF patients, with personalised biomechanical models.
Bo Wang, Shuo Wang, Chao Gao, D. Scott Lim, Rutao Wang, Xin Meng, Ying Liu, Cun‐jun Zhu, Yoshinobu Onuma, Yunbing Wang, Patrick W.J.C. Serruys, Runlin Gao, Randall J. Lee, Ling Tao   +13 more
wiley   +1 more source

Hepatitis C virus-associated cardiomyopathy: A review of pathogenesis. [PDF]

World J Virol
Bharaj IS, Singh G, Brar AS, Kacheria A, Kahlon J, Mohmand B, Sohal A, Yeneneh BT.   +7 more
europepmc   +1 more source